This pill promises to slow down dogs' aging process: all about how it works and when it will be released

A meaty-tasting tablet that promises to slow down aging in dogs. It may sound like science fiction, but it's the project that an American biotech Loyal is working on . LOY-002 is an experimental drug designed to extend the healthy life expectancy of pets, especially older ones.

The mechanism is not entirely novel. Basically, it's based on a well-known principle of longevity research: caloric restriction, i.e. the reduction of energy intake which, in various studies, has been associated with longer life. In this case, however, the aim is to achieve the same effect without changing the diet.

The drug acts on a key metabolic element: IGF-1, a growth hormone which, when elevated in adulthood, can contribute to accelerated cellular aging. By reducing its activity, the LOY-002 tablet aims to slow down what is known as the biological clock, in order to preserve vital functions for longer.

Research status

The commercialization process is still underway, but things are moving ahead. The drug has already passed important milestones with the Food and Drug Administration, the US agency that regulates drugs and healthcare products. In particular, an essential component relating to animal safety has been accepted, a crucial step for any veterinary treatment.

What remains to be done, however, is to complete the main efficacy study, which is essential for final approval. According to the company's forecasts, the product is expected to be available between 2026 and 2027, but with one important caveat: this is not a miracle cure. Veterinarians themselves stress that the drug, if approved, will only be a support and can never replace daily care or attention to the dog's well-being.

A drug that intrigues and divides

The announcement immediately went viral, and LOY-002's media success is easy to understand. It touches on a sensitive point: the bond between humans and dogs, a relationship that has its roots tens of thousands of years in the past. Anyone who lives with a dog knows: time spent together always seems too short.

The prospect of extending your pet's life gives rise to a powerful, almost inevitable sense of hope. So it's hardly surprising that news of this kind spreads rapidly. And yet, this is precisely where the first questions arise. To what extent does this research really serve the animal's well-being, and how much of it is a human desire to delay the loss of a four-legged companion?

As the enthusiasm grows, so does the thought process. Intervening in biological processes to prolong life raises profound questions, especially when it comes to other species. On the one hand, improving the quality of life of an elderly dog is a widely shared objective. On the other, there's the risk of transforming this innovation into a market built on emotions.

It's a fine line. On the one hand, there's science trying to provide concrete solutions, and on the other, the temptation to chase after a form of control over time. LOY-002 stands precisely at this point, poised between progress and limits. But as the research continues, one thing remains clear: no pill can replace what really matters to a dog: daily care, attention and love.

Source : Loyal

(©GreenMe.it 2026/Managing editor: Malvina Parker - The Global Nature/Picture: Alvan Nee via Unsplash)